Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland

BACKGROUND: Despite positive results from phase II and observational studies, Rituximab (RTX) is not currently approved for multiple sclerosis (MS) treatment and can only be used off-label. OBJECTIVE: To characterize MS patients treated with RTX and investigate its effectiveness and safety in a clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Scotti, Barbara, Disanto, Giulio, Sacco, Rosaria, Guigli, Marilu’, Zecca, Chiara, Gobbi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951582/
https://www.ncbi.nlm.nih.gov/pubmed/29758075
http://dx.doi.org/10.1371/journal.pone.0197415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951582/
https://www.ncbi.nlm.nih.gov/pubmed/29758075
http://dx.doi.org/10.1371/journal.pone.0197415

Ejemplares similares